Testing and treating newborns for spinal muscular atrophy: saving lives and healthcare costs

Image - Testing and treating newborns for spinal muscular atrophy: saving lives and healthcare costs

Gene therapy for spinal muscular atrophy might have a high up-front price tag. But by screening and treating infants early, the therapy can save both lives and money in the long term.

By the time an infant with SMA starts showing symptoms, they've already lost 90 per cent of their nerves – which is why early detection and treatment is so important

People related to this news
image - Sophy Shih 19
Dr Sophy Shih
Senior Research Fellow
image - 1L8A0602 Cropped
Professor Georgina Chambers
Professor, Director of the National Perinatal Epidemiology and Statistics Unit
Ph 0408664490
Date Published
Tuesday, 3 August 2021
Back to Top